WVE Research and Charts

WVE - WAVE Life Sciences Ltd (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-05 (Delayed quote data 2025-09-12)

Last 6.97	Change ⇓ -0.19 (-2.65%)	Volume 1,851,383
	Open 7.15	High 7.18	Low 6.95

8EMA (Daily) 7.71	40EMA (Daily) 8.38	50EMA (Daily) 8.32	STO (Daily) 7.467	MACD Hist (Daily) -0.608
8EMA (Weekly) 8.363	40EMA (Weekly) 8.42	50EMA (Weekly) 8.39	STO (Weekly) 67.154	MACD Hist (Weekly) 0.160


Company Profile
WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.